PDI Therapeutics Inc.

Inhibikase Therapeutics, Inc. launched the last initial public offering of 2020 by a biopharmaceutical company, bringing the year’s total to 86 IPOs in the US. First-time offerings already are off to

Biopharmaceutical companies continued their domination of the market for initial public offerings during the week of 8-12 June with IPOs from Avidity Biosciences Inc. , Generation Bio Co. , Vaxcyte

GlaxoSmithKline PLC 's six-year old drug development collaboration with Avalon Ventures has resulted in a single acquisition by GSK. The companies announced on 11 September that GSK will buy Sitari P

IN VITRO DIAGNOSTICS AccuraGen Inc. AccuraGen raises $40mm through Series B round AccuraGen Inc. (cancer diagnostics) raised $40mm through its Series B round from investors including Junson Ca